Cleared Traditional

Kinepict Medical Imaging Tool 4.0 (K202056) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K202056 · Kinepict Health, Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2021
Decision
413d
Days
Class 2
Risk

K202056 is an FDA 510(k) clearance for the Kinepict Medical Imaging Tool 4.0. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Kinepict Health, Ltd. (Budakeszi, HU). The FDA issued a Cleared decision on September 10, 2021 after a review of 413 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Kinepict Health, Ltd. devices

Submission Details

510(k) Number K202056 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 24, 2020
Decision Date September 10, 2021
Days to Decision 413 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
306d slower than avg
Panel avg: 107d · This submission: 413d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 799
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K202056.
Collaboration Live
K212777 · Philips Ultrasound, Inc. · Sep 2021
JiveX (Model Number / Release: 5.3)
K212321 · Visus Health IT GmbH · Sep 2021
KONICAMINOLTA DI-X1
K212685 · Konica Minolta, Inc. · Sep 2021
EFAI PACS Picture Archiving and Communication System
K211257 · Ever Fortune.Ai, Co., Ltd. · Sep 2021
ADAS 3D
K212421 · Adas3D Medical S.L. · Sep 2021
RBknee
K203696 · Radiobotics Aps · Aug 2021